Revised SPC: Imfinzi (durvalumab) 50 mg/mL concentrate for solution for infusion

SPC has been updated with information on suspected pneumonitis, advising that it should be confirmed with radiographic imaging and other infectious and disease-related aetiologies excluded, and managed as recommended in section 4.2.

Source:

electronic Medicines compendium